Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Jubilant Pharmova Plunges 5%; BSE HEALTHCARE Index Down 1.2%
Mon, 4 Nov 10:42

Jubilant Pharmova Plunges 5%; BSE HEALTHCARE Index Down 1.2%Image source: Nikada/www.istockphoto.com

Jubilant Pharmova share price has plunged 5% and is presently trading at Rs 1,207.7.

Meanwhile, the BSE HEALTHCARE index is at 43,679.2 (down 1.2%).

Among the top losers in the BSE HEALTHCARE index today are Sun Pharma (down 3.9%) and CAPLIN POINT (down 3.7%).

KIMS (up 2.9%) and MAX HEALTHCARE INSTITUTE (up 1.4%) are among the top gainers today.

Over the last one year, Jubilant Pharmova has moved up from Rs 374.5 to Rs 1,207.7, registering a gain of Rs 833.2 (up 222.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,271.8 to 43,679.2, registering a gain of 60.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 222.5%), SUVEN PHARMACEUTICALS (up 128.4%) and Glenmark Pharma (up 122.9%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 78,569.4 (down 1.6%).

The top losers among the BSE Sensex today are Sun Pharma (down 3.9%) and NTPC (down 3.8%). The most traded stocks in the BSE Sensex are ICICI Bank and Reliance Ind..

In the meantime, NSE Nifty is at 23,919.1 (down 1.6%). IOC and Hero Motocorp are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 63,874.9 to 78,569.4, registering a gain of 14,694.5 points (up 23.0%).

Jubilant Pharmova Financial Update...

Jubilant Pharmova net profit grew 93.2% YoY to Rs 1,026 million for the quarter ended September 2024, compared to a profit of Rs 531 million a year ago. Net sales rose 4.3% to Rs 17,523 million during the period as against Rs 16,803 million in July-September 2023.

For the year ended March 2024, Jubilant Pharmova reported 212.0% increase in net profit to Rs 727 million compared to net loss of Rs 649 million during FY23. Revenue of the company grew 6.7% to Rs 67,029 million during FY24.

The current Price to earnings ratio of Jubilant Pharmova, based on rolling 12 month earnings, stands at 33.6.


Equitymaster requests your view! Post a comment on "Jubilant Pharmova Plunges 5%; BSE HEALTHCARE Index Down 1.2%". Click here!